Pre-clinical proof-of-concept for a novel inhibitor of vascular calcification

• Unité de recherche: INNOSUISSE
• Numéro de projet: 25174.1 PFLS-LS
• Titre du projet anglais: Pre-clinical proof-of-concept for a novel inhibitor of vascular calcification

Description succincte (Allemand)

Pre-clinical proof-of-concept for a novel inhibitor of vascular calcification

Description succincte (Anglais)

Pre-clinical proof-of-concept for a novel inhibitor of vascular calcification

Résumé des résultats (Abstract) (Allemand)

Inositec#s proprietary platform of small molecules have been derived from a natural compound and engineered for therapeutic potential. The present project aims to establish pre-clinical proof-of-concept for a novel inhibitor of vascular calcification for chronic kidney disease patients. Vascular calcification is a common consequence of renal insufficiency leading to cardiovascular disease for which there are currently no approved treatments.

Résumé des résultats (Abstract) (Anglais)

Inositec#s proprietary platform of small molecules have been derived from a natural compound and engineered for therapeutic potential. The present project aims to establish pre-clinical proof-of-concept for a novel inhibitor of vascular calcification for chronic kidney disease patients. Vascular calcification is a common consequence of renal insufficiency leading to cardiovascular disease for which there are currently no approved treatments.